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Objective:We sought to understand the magnitude of the risk that drivers with epilepsy (DWE) contribute to
motor vehicle accidents (MVAs) compared to other drivers.
Methods:Weperformed an evidence-based, systematic review using the American Academy of Neurology (AAN)
guideline methodology.
Results: Contributory evidence consisted of six Class II studies and one Class III study. Two articles reported a
trend toward a decreased rate of overall MVA rates for DWE when compared with the general population with
a relative risk (RR) of 0.86 (95% CI: 0.65–1.14) (Class III) and a RR of 1.00 (95% CI: 0.95–1.06) (Class II);
both studies used patient report to ascertain MVA rates. Three Class II studies reported either a trend toward
or an increased risk of MVA rates for DWE when compared with the general population with a RR of 1.62 (95%
conﬁdence interval (CI): 0.95–2.76), as ascertained by insurance, emergency department, and physician
reporting databases, a RR of 1.73 (95% CI 1.58–1.90), as ascertained by police reports, and a RR of 7.01 (95% CI
2.18–26.13), as ascertained by casualty department visits. One Class II study showed that, compared to fatal
crashes with DWE, fatal crashes were 26 times more likely to occur because of other medical conditions and
156 times more likely to occur because of alcohol abuse. Motor vehicle accident crashes due to seizures in
DWE occurred in one out of every 2800 MVAs, as reported in another Class II study.
Conclusions: The evidence for the difference in MVA rates in DWE compared to the general population is incon-
sistent, andno conclusion can bemade. Importantmethodological differences across the studies contribute to the
imprecision. Future research should be performed using objective measures rather than self-reporting of MVAs
by DWE and “miles driven” as the denominator to calculate MVA rates.© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Drivers with epilepsy (DWE) are subject to driving restrictions
throughout the United States. The recommended duration of driving
restriction after seizure occurrence for DWE is inconsistent, and the
evidence to support any restriction is obscure. The quality of life
for persons with epilepsy (PWE) is adversely affected when seizure
severity and frequency limit social activities and independence, includ-
ing driving [1]. We sought to begin to understand how to formulate an
appropriate driving restriction by determining themagnitude of the riskvehicleaccidents;PWE,persons
1 516 325 7001.
ng1@NSHS.edu (M.E. Fleming),
rden).
. This is an open access article underthat DWE contribute to highway accidents compared to drivers with or
without other medical conditions.
2. Methods
We performed a systematic, evidence-based review using the
American Academy of Neurology (AAN) guideline methodology. We
searched PubMed for all articles published from 1996 to the present,
limiting the search to articles available in English. The search strategy in-
cluded the Boolean operator AND between the parenthetical statements
“(epilepsyOR seizureOR seizure disorderOR loss of consciousness)” and
“(driving OR motor vehicle accident OR driving accident OR driving
risk).” This search yielded 494 abstracts, which were each reviewed by
two authors for relevance. Twenty-eight papers met criteria for further
review and were classiﬁed according to the AAN prognostic criteria.
After review by all four authors, eight papers were classiﬁed as havingthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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the lack of addressing the question or lack of an appropriate comparator
arm. Estimated rates of epilepsy prevalence were applied in two papers
[2,3].
3. Results
The evidence for rates of MVAs in DWE compared to the general
population consisted of one Class I study, four Class II studies, and one
Class III study. The Class I study by Sillanpaa and Shinnar [4] suggested
that DWE do not have an increased risk of MVAs. However, this study
had a small sample size of 81 DWE and 96 comparator drivers and a
one-year assessment period; therefore, the results are imprecise and,
overall, not contributory. Two articles showed a trend towards de-
creased risk of overall MVA rates in DWEwhen comparedwith the gen-
eral population: Taylor et al. [5], a Class III study which used self-report
questionnaires from drivers with epilepsy and utilized the denominator
of 1000 driver-years, reported a relative risk (RR) of 0.86 (95% CI: 0.65–
1.14); and McLachlan et al. [6], a Class II study, reported a RR of 1.00
(95% CI: 0.95–1.06) and used self-reported questionnaires from DWE
who were identiﬁed through physician report to the transportation
registry, with a denominator of MVAs per year.
However, the three additional Class II studies showed that DWE have
increasedMVA rates compared to the general population. Kwon et al. [7]
reported a RR of 1.62 (95% CI: 0.95–2.76) and used medical and insur-
ance databases to determine the occurrence of crashes in persons with
epilepsy, with a denominator of 1000 person-years. Vernon et al. [8] re-
ported a RR of 1.73 (95% CI: 1.58–1.90 for “unrestricted” drivers) and a
RR of 1.47 (95% CI: 1.06–2.03 for “restricted drivers”). Drivers were cate-
gorized as “restricted” based on a physician evaluation of the severity of
their medical condition and whether it caused impairment in driving
ability. Driver's licenses with restrictions were divided into twelve levels
in which driving was restricted to a certain speed, area, and/or time of
day; privileges may have also been completely denied based on this
evaluation. This study determinedMVA rates using police reports in per-
sons with driver's licenses that had previously registered medical condi-
tions, with a denominator of 10,000 license-days. Lings [9] reported a RR
of 7.01 (95% CI: 2.18–26.13) for DWE compared to the general driving
population. In this study, the MVA rates were determined by reports
from the casualty departments with a denominator of 1000 person-
years. This study also had fewer outcomes than the other reports, as ev-
idenced by the wide conﬁdence interval (see Table 1).
Two other Class II studies provided information on comparative MVA
rates butweremore speciﬁc in their scope: one addressed seizure-related
crashes in DWE, and one addressed fatal crashes. From the ﬁrst of these
Class II studies, seizure-related crashes in DWE are rare, occurring in
one out of every 2800 MVAs [2]. This study used crashes reported by
law enforcement agencieswith a denominator of one billionmiles driven.
From the remaining Class II study, DWE are at least 50% less likely to be
involved in fatal crashes than other drivers [3]. Fatal crashes due to alco-
hol abuse and alcoholism occurred 156 times more often than those in
DWE, and overall, drivers with other medical conditions cause fatal acci-
dents 26 times more than DWE [3]. These medical conditions included
cardiac conditions, diabetes, and conditions related to alcohol use. This
study used US death certiﬁcates provided by the National Center for
Health Statistics of the Centers for Disease Control and Prevention, with
a denominator of 100,000 person-years [3].
4. Discussion
The overall rates ofMVAs in DWE fromone Class I study, four Class II
studies and one Class III study that included case-control and retrospec-
tive cohort study designs were not consistent, prohibiting the formula-
tion of any conclusions. However, the study methods reveal reasons for
the inconsistent results aswell as sources of potential bias. For example,
the short period of driving restriction from the study of Vernon et al. [8]may have inﬂuenced the results toward reports by DWE with more
poorly controlled seizures who may have had more MVAs.
The ascertainment methods used in these studies would also con-
tribute to the bias. The two publications showing the lowest risk utilized
self-reported questionnaire surveys for the occurrence of MVAs [5,6].
This methodology could bias the results toward an underestimation of
risk. The three publications showing the greatest risk were by Kwon
et al. [7], Vernon et al. [8], and Lings [9]. These studies used police
reports, hospital records, andmedical databases to captureMVA events.
These methods are likely more objective, complete, and accurate than
self-report questionnaires.
In the study ofMcLachlan et al. [6] and Kwon et al. [7], the amount of
time spent driving and the distance driven by PWEwas not captured. In
other studies, license-days [8], driving-years [5], and person-years with
epilepsy [9] were used as denominators to calculate MVA rates. The
varied denominators almost certainly preclude consistent results, but
it is unclear if there is a bias associated with any of these approaches.
It is likely, however, that the use of license-days or holding a license as
a denominator does not accurately represent the amount of miles
DWE are actually driving, since drivers with medical conditions
including epilepsy drive less than unaffected drivers [10]. Motor vehicle
accident rates in future studies should be adjusted from miles driven;
we suggest that the use of billions of miles driven, derived using
roadway sensor data and fuel taxes by Drazkowski et al. [2], is a more
accurate methodology for deriving the denominator.
Seizure-related crashes appear to be rare, occurring in one out of
every 2800 MVAs [2]. However, the strength of evidence for this is
low, based on one Class II study. The strength of evidence is also low
that fatal crashes for DWE are markedly less frequent than fatal crashes
due to alcohol abuse or alcoholism and other medical conditions.
Drivers with epilepsy are at least 50% less likely to be involved in fatal
crashes than other drivers [3].
The role of antiepileptic drugs (AEDs) as a factor in the occurrence of
MVAs is complex. Consistent information from two large studies shows
that AEDnonadherence doubles theMVA risk [11], the risk ofMVAs due
to seizures, and the risk of losing driving privileges [12]. However, the
adverse cognitive effects of taking AEDs, such as impaired attention
and limited visual scanning, may increase the risk of driving errors, as
suggested by Mills et al. [13].
Limitations of the reports used as evidence include the following:
there was no indication as to who was at fault for the accident and it
is not clear whether MVAs occurred in the setting of adverse weather,
mechanical failure, or cellphone usage including texting. This review
also points out what is well known; other medical conditions such as
cardiac disease, diabetes, and conditions related to alcohol have an in-
creased risk of MVAs even compared to epilepsy, and they should be
evaluated under a critical lens.
5. Conclusions
Our systematic review does not strongly support or refute an in-
creased risk of MVA for DWE. However, the evidence does reveal how
the ‘truth’ regarding this risk could be ascertained in future studies.
First, studies with more objective ascertainment methods showed
slightly increased risk compared to those with self-reported methods
and are likely more accurate. Second, the MVA occurrences should be
obtained with a denominator of ‘miles driven’ which would increase
the accuracy of the evidence and would probably show an even further
increased risk. Important factors which have already been shown to
increase MVA risk in DWE should be accounted for when comparing
DWE to the general population. These include an objective assessment
of AED adherence and the relative MVA risk imparted by taking AEDs
known to have adverse cognitive or sedative effects. Finally, the seizure
frequency should be accounted for, at least by adjusting for the
minimum seizure-free period used to permit driving in the states of the
study populations. More information on MVA risk for DWE compared to
Table 1
Prognostic classiﬁcation of selected articles comparing MVA rates in DWE.
Author and Year Method Location and
sample size
Source of data MVA rates Completeness Classiﬁcation for
prognostic accuracy
Drazkowski
et al. [2]
Retrospective cohort study
Motor vehicle crashes related to seizures
versus other medical conditions and
other crashes for people without medical
conditions after driving restriction for
DWE for three monthsa
Arizona, USA
136 seizure-related crashes
614,000 total crashes
Arizona trafﬁc crash report forms provided by law
enforcement agencies
1.1 per billion miles driven for DWE
2800 per billion miles driven for drivers
without epilepsy
RR = 3.9 × 10−4 (conﬁdence interval could
not be calculated)
100% Class II
Kwon et al. [7] Retrospective cohort study Alberta, Canada
10,240 DWE
40,960 controls
Alberta Health Care Insurance Plan Registry (includes
N99% of the population); Hospital discharge abstract
database, ER visit database and physicians' claim
database and “vital statistics” database
1.86 MVAs per 1000 person-years for DWE
1.15 MVAs per 1000 person-years for
drivers without epilepsy
RR = 1.62 (95% CI 0.95–2.76)
100% Class II
Lings [9] Retrospective cohort study Odense, Denmark
159 DWE
559 controls
Danish Central Person Register, Patient Register at
Odense University Hospital, Accident Analysis
Group's Register at Odense University Hospital,
Central Register of Driving Licenses at the National
Commissioner of the Danish Police, and the Odense
Police Driving Register
9.4 MVAs per 1000 person-years for DWE
1.34 MVAs per 1000 person-years for
drivers without epilepsy
RR = 7.01 (95% CI: 2.18–26.13)
100% Class II
McLachlan et al.
[6]
Retrospective cohort study Alberta and Ontario, Canada
425 people with epilepsy
responded
375 controls responded
Ontario: Ministry of Transportation registry
(physician-required reporting)
Alberta: physician-discretionary reporting (no registry)
Subjects were selected from epilepsy clinics located in
Ontario and Alberta
Self-completion surveys sent to people with history of
epilepsy and controls
0.09 MVA in DWE in the past year
0.09 MVA in drivers without epilepsy in
the past year
RR = 1.00 (95% CI: 0.95–1.06)
MVA in lifetime
0.6 MVA in drivers with epilepsy per
lifetime
0.6 MVA in drivers without epilepsy per
lifetime
RR = 0.99 (95% CI: 0.82–1.19)
80% Class II
Sheth et al. [3] Case control
Annual totals and disease-speciﬁc risk for
fatal crashes associated with seizures and
other medical conditionsa
USA
86 seizure-related fatal crashes
44,027 total fatal crashes
US death certiﬁcates provided by the National Center
for Health Statistics of the Centers for Disease Control
and Prevention
8.6 fatal seizure-related crashes per
100,000 person-years
22.51 fatal crashes in general population
per 100,000 person-years
RR = 0.38 (95% CI 0.3–0.5)
100% Class II
Sillanpaa and
Shinnar [4]
Prospective cohort study Turku, Finland
81 DWE
96 persons without epilepsy
Patient records in hospitals, institutions, day care
centers, special schools, private surgeons, and
National Health Service records
0 MVAs in 81 DWE over one year
0 MVAs in 96 drivers without epilepsy over
one year
RR = 0
100% Class I
Taylor et al. [5] Retrospective cohort study United Kingdom
16,958 DWE
8888 controls
Driver and Vehicle Licensing Agency and associated
medical department records
Self-completion surveys sent to people with history
of epilepsy and controls
83 MVAs per 1000 driving-years for DWE
96 MVAs per 1000 driving-years for
drivers without epilepsy
RR = 0.86 (95% CI 0.65–1.14)
71% Class III
Vernon et al. [8] Case control
Comparison of rates of MVAs
experienced by DWE (in medical
conditions licensing program) versus
controls
Utah, USA
2709 DWE
1,750,918 total licensed drivers
Police crash reports obtained from the Utah
Department of Transportation as well as death
certiﬁcate data from the Utah Department of Health
2.69 MVAs (unrestricted DWE) per 10,000
license-days
1.55 MVAs (unrestricted controls) per
10,000 license-days
Unrestricted: RR = 1.73 (95% CI 1.58–1.9)
2.67 MVAs (restricted DWE) per 10,000
license-days
1.81 MVAs (restricted controls) per 10,000
license-days
Restricted: RR = 1.47 (95% CI 1.06–2.03)
100% Class II
a Population estimates of epilepsy cases used.
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114 P.A. Naik et al. / Epilepsy & Behavior 47 (2015) 111–114the general population could inform the formulation of appropriate and
perhaps individualized driving restrictions.
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